Innovator IBD 50 ETF Rating $34.95 -0.61 (-1.72%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Innovator IBD 50 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FFTY Aggregate RatingModerate Buy 2.75Holdings in FFTY have an aggregate rating of Moderate Buy based on 371 analyst ratings issued in the past year covering 24 companies (71.8% of the portfolio).FFTY Aggregate Price Target$34.95High Prediction$34.95Average Prediction$34.95Low Prediction$34.95Holdings in FFTY have an aggregate price target of $34.95 and a range of $34.95 to $34.95 covering 24 companies (71.8% of the portfolio).FFTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD 50 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 FFTY Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings3.78%ECOOkeanis Eco Tankers$77.96+0.5%Moderate Buy$59.52 -23.7%62.7274 of 5 starsNews Coverage3.56%WTWisdomTree$23.730.0%Moderate Buy$23.66 -0.3%72.3848 of 5 stars3.55%TVTXTravere Therapeutics$59.83-0.7%Moderate Buy$68.10 13.8%121.9104 of 5 starsPositive NewsAnalyst Forecast3.54%NTRANatera$390.790.0%Moderate Buy$330.83 -15.3%231.5899 of 5 starsTrending News3.50%TGTXTG Therapeutics$56.00-3.6%Hold$63.00 12.5%93.4009 of 5 starsAnalyst Upgrade3.45%ETONEton Pharmaceuticals$55.61-2.6%Moderate Buy$67.50 21.4%64.5775 of 5 starsPositive NewsAnalyst Upgrade3.45%KNSAKiniksa Pharmaceuticals International$76.08-2.5%Moderate Buy$87.38 14.8%104.1883 of 5 starsPositive News3.45%HNGEHinge Health$92.27-2.0%Moderate Buy$103.71 12.4%183.562 of 5 starsAnalyst ForecastInsider Trade3.37%MUMicron Technology$1,071.88-2.2%Buy$1,296.47 21.0%384.977 of 5 starsTrending NewsUpcoming EarningsAnalyst ForecastAnalyst Revision3.11%AUGOAura Minerals$85.34-8.0%Moderate Buy$86.95 1.9%73.8681 of 5 starsInsider TradeGap Down3.09%LIFEEthos Technologies Inc. Class A Common Stock$33.91-6.3%Moderate Buy$32.29 -4.8%71.9167 of 5 starsNews CoveragePositive News3.04%HALOHalozyme Therapeutics$112.44-2.3%Moderate Buy$91.20 -18.9%133.0677 of 5 stars3.03%ATEYYAdvantest$213.00-1.7%Buy32.6146 of 5 starsNews Coverage3.02%ZETAZeta Global$29.82-1.0%Moderate Buy$30.77 3.2%142.2341 of 5 starsNews Coverage3.02%AMDAdvanced Micro Devices$614.61-1.5%Moderate Buy$565.13 -8.1%472.8619 of 5 starsTrending News3.00%VCTRVictory Capital$106.31+1.3%Hold$105.71 -0.6%83.7429 of 5 stars2.93%ATIATI$184.16-1.3%Buy$232.00 26.0%104.3803 of 5 starsInsider Trade2.86%URGNUrogen Pharma$41.63-2.6%Moderate Buy$52.38 25.8%102.7186 of 5 starsHigh Trading Volume2.83%GKOSGlaukos$153.63-3.9%Moderate Buy$180.54 17.5%153.2184 of 5 starsPositive NewsAnalyst Forecast2.10%OSCROscar Health$30.51-0.5%Hold$33.90 11.1%134.5594 of 5 starsInsider Trade2.10%ANETArista Networks$203.25-0.9%Buy$227.80 12.1%233.9682 of 5 starsTrending NewsInsider Trade2.01%TERTeradyne$389.14-2.4%Moderate Buy$396.80 2.0%164.1983 of 5 starsTrending NewsAnalyst Upgrade2.01%FIVEFive Below$227.41-2.1%Moderate Buy$300.70 32.2%324.7405 of 5 stars2.00%NEMNewmont$123.57-2.9%Moderate Buy$133.07 7.7%244.4649 of 5 starsTrending NewsGap Down This page (NYSEARCA:FFTY) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FFTY Stock Alerts